FC
AMPH icon

FORA Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

FORA Capital’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,903
Closed -$200K – 499
2025
Q1 		$200K Buy
+6,903
New +$220K 0.02% 445
2023
Q4 		– Sell
-11,219
Closed -$516K – 427
2023
Q3 		$516K Buy
+11,219
New +$612K 0.05% 330
2021
Q3 		– Sell
-1,338
Closed -$27K – 369
2021
Q2 		$27K Buy
+1,338
New +$25.2K 0.01% 797

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

FORA Capital's AMPH Position: Q2 2025 in Review

FORA Capital sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2025, closing a stake of 6,903 shares — an estimated $200K sold.

FORA Capital first reported a position in AMPH in Q2 2021 and held it in 3 quarters. The position peaked at $516K in Q3 2023. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2025.

  • FORA Capital reported no remaining Amphastar Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • FORA Capital sold 6,903 Amphastar Pharmaceuticals shares in Q2 2025, an estimated $200K.
  • FORA Capital first reported a position in Amphastar Pharmaceuticals in Q2 2021 and held it in 3 quarters.
  • FORA Capital's Amphastar Pharmaceuticals position peaked at $516K in Q3 2023.
  • 245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2025.

Based on FORA Capital's 13F filing for Q2 2025, filed 13 Aug 2025.